Biofil Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022
For the full year, sales was INR 223.82 million compared to INR 357.5 million a year ago. Revenue was INR 225.33 million compared to INR 365.5 million a year ago. Net income was INR 6.98 million compared to INR 12.41 million a year ago. Basic earnings per share from continuing operations was INR 0.44 compared to INR 0.77 a year ago. Diluted earnings per share from continuing operations was INR 0.44 compared to INR 0.77 a year ago.